Liver Cancer News and Articles

Return to Library

Recent Liver Cancer News and Articles

• New Liver Cancer Data Have Been Reported by Investigators at Baylor University College of Medicine
• Research Reports from Huazhong University of Science and Technology Provide New Insights into Apoptosis
• Study Data from Chung Ang University Hospital Update Understanding of Liver Cancer
• Patent Application Titled \"Small Molecule Modifiers of Microrna Mir-122\" Under Review
• Research Findings from Gunma University Update Understanding of Cholangio Cancer
• Researchers from University of Barcelona Detail Findings in Public Health
• Studies from First Affiliated Hospital Update Current Data on Transplantation
• Studies from University of Namur Have Provided New Data on Small Interference RNAs (siRNAs)
• Studies from University of Tokyo Reveal New Findings on Hepatocellular Cancer

---

New Clinical Oncology Study Findings Have Been Reported from Mount Sinai School of Medicine

2013 JAN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Clinical Oncology are discussed in a new report. According to news reporting originating in New York City, New York, by NewsRx journalists, research stated, "Chronic fibrotic liver diseases such as viral hepatitis eventually develop liver cirrhosis, which causes occurrence of hepatocellular carcinoma (HCC). Given the limited therapeutic efficacy in advanced HCC, prevention of HCC development could be an effective strategy for improving patient prognosis."

The news reporters obtained a quote from the research from the Mount Sinai School of Medicine, "However, there is still no established therapy to meet the goal. Studies have elucidated a wide variety of molecular mechanisms and signaling pathways involved in HCC development. Genetically-engineered or chemically-treated experimental models of cirrhosis and HCC have been developed and shown their potential value in investigating molecular therapeutic targets and diagnostic biomarkers for HCC prevention."

According to the news reporters, the research concluded: "In this review, we overview potential targets of prevention and currently available experimental models, and discuss strategies to translate the findings into clinical practice."

For more information on this research see: Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Current Cancer Drug Targets, 2012;12(9):1129-59. (Bentham Science Publishers - www.benthamscience.com; Current Cancer Drug Targets - www.benthamscience.com/ccdt/index.htm)

Our news correspondents report that additional information may be obtained by contacting Y. Hoshida, Mount Sinai Liver Cancer Program, Tisch Cancer Institute, Division of Liver Diseases, Dept. of Medicine, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, United States.

Keywords for this news article include: Genetics, New York City, United States, Clinical Oncology, Experimental Models, Hepatocellular Carcinoma, North and Central America.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC